News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PharmaNetics, Inc. (PHAR) To Pursue Next Stage Of Litigation Against Aventis (AVE)



10/19/2005 5:09:50 PM

RALEIGH, N.C.--(BUSINESS WIRE)--May 23, 2005--PharmaNetics, Inc. announced today that on May 20, 2005, the U.S. District Court for the Eastern District of North Carolina entered an order that clears the way for PharmaNetics to immediately appeal the Court's previous rulings granting summary judgment against PharmaNetics so that the Company will not have to go forward with a trial prior to filing an appeal in the United States Court of Appeals for the Fourth Circuit. PharmaNetics filed its formal notice of appeal today appealing the Court's entry of final judgment against PharmaNetics. The Company looks forward to the opportunity to argue its full case against Aventis before the Court of Appeals and thereafter to eventually prove its case at trial.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES